Phelan McDermid Syndrome Market: How Are SHANK3-Targeted Therapies...

ha aggiunto una foto Health

2026-07-28 10:23:19 -

Phelan McDermid Syndrome Market: How Are SHANK3-Targeted Therapies and IGF-1 Analogues Opening Therapeutic Avenues for Autism-Related Genetic Disorders?

Phelan-McDermid syndrome — the neurodevelopmental disorder caused by deletion or mutation of the SHANK3 gene on chromosome 22q13.3, characterized by severe intellectual disability, autism spectrum disorder, hypotonia, speech absence, and seizures — has historically been managed entirely through supportive and behavioral interventions, but the Phelan McDermid Syndrome Market is now...

0 Commenti 0 condivisioni 33 Views 0 Anteprima